Recently, Berkshire Hathaway (NYSE:BRK/A, NYSE:BRK/B) has increased their stake in a pharmaceutical company known as Teva Pharmaceuticals Industries (NYSE:TEVA, TASE:TEVA).Teva Pharmaceutical Industries specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Incorporated in 1901 and listed on the New York Stock Exchange in 2012, it is the largest generic drug manufacturer in the world and one of the 15 largest pharmaceutical companies worldwide. However, due to huge losses in 2016, the numbers don’t look very well.

The PowerPoint presentation attached here shows my personal take on the company.

Before making any decision, please do your own due diligence!

Feel free to share with me your thoughts about Teva in the comments section below! 🙂